Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT06988475) titled 'DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations' on May 16.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Cancer Research UK
Condition:
Solid Tumour
Haematological Malignancy
Malignant Neoplasm
Neoplasms by Histologic Type
Neoplasms by Site
Cancer
Malignancy
Glioma
Neuroblastoma
Gastric Cancer
Soft Tissue Sarcoma
Intervention:
Drug: Capmatinib
Recruitment Status: Recruiting
Phase: Phase 2/Phase 3
Date of First E...